Cxbladder - Bladder Cancer Detection Test - News

By: Cxbladder  05-Apr-2012
Keywords: Diagnostic Tests, Molecular Diagnostics

In the largest study to date of the gender gap in cancer, scientists from the Cancer Prevention Institute of California, the Harvard School of Public Health, and the Karolinska Institute in Stockholm, analyzed almost 15 million cases of cancer in no fewer than 60 countries and found men are at higher risk for 32 of 35 cancers. Notably, men have four times the risk that women do for five cancers - cancers of the larynx, hypopharynx (the part of the throat that connects to the esophagus), lip, urinary bladder and Kaposi sarcoma.

Fremont, CA (PRWEB) January 17, 2012

For 14 cancers the risk among men is double that of women. And for five cancers - cancers of the larynx, hypopharynx (the part of the throat that connects to the esophagus), lip, urinary bladder and Kaposi sarcoma - men have more than four times the risk of women.

"Differences this large are unusual," says senior author and CPIC Research Scientist Dr. Ellen Chang of the CPIC. "To give you a sense of how strong male gender is as a risk factor for many of these fourteen cancers, it's about equivalent to having a first-degree family history of cancer. By quadrupling the risk of five cancers, being male is an exceptionally strong risk factor- it's like having multiple first-degree relatives with cancer."

In the largest study to date of the gender gap in cancer, scientists from CPIC, the Harvard School of Public Health, and the Karolinska Institute in Stockholm, Sweden, analyzed almost 15 million cases (in no fewer than 60 countries) of 35 different types of cancer to understand how men and women differ with respect to cancer risk. The source of this information was the International Agency for Research on Cancer (IARC).

The authors suggest that gender differences in cancer risk for some sites could be explained in part by different exposures to environmental and behavioral factors such as smoking, occupation, and alcohol consumption, but that the majority of the gender gap probably results from key biological factors that differ between all males and females.

After considering the consistency of the excess cancer risks across different countries and over time, and in view of known risk factors for each cancer type, the authors conclude that for many cancers, the gender gap is "entirely unexplained." Therefore, the authors urge further research to understand the biological basis of these remarkable differences.

"If we could find out what causes the male excess of cancer and somehow eliminate it, we could prevent roughly one-third of all cancer," Chang said. "Simply being male is responsible for a huge percentage of our worldwide cancer burden."

###

Keywords: Diagnostic Tests, Molecular Diagnostics